CcpA and CodY Regulate CRISPR-Cas System of Streptococcus mutans

被引:2
|
作者
Kang, Da-Young [1 ]
Kim, Andy [2 ]
Kim, Jeong Nam [1 ,3 ]
机构
[1] Pusan Natl Univ, Coll Nat Sci, Dept Integrated Biol Sci, Busan, South Korea
[2] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX USA
[3] Pusan Natl Univ, Coll Nat Sci, Dept Microbiol, Busan, South Korea
基金
新加坡国家研究基金会;
关键词
Streptococcus mutans; CRISPR-Cas system; CcpA; CodY; (p)ppGpp; PHOSPHOTRANSFERASE SYSTEM; ORAL STREPTOCOCCI; GENE-EXPRESSION; CATABOLITE REPRESSION; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; VIRULENCE TRAITS; METABOLISM; PROTEIN; INDUCTION;
D O I
10.1128/spectrum.01826-23
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) genes are widely recognized as bacterial adaptive immune systems against invading viruses and bacteriophages. The oral pathogen Streptococcus mutans encodes two CRISPR-Cas loci (CRISPR1-Cas and CRISPR2-Cas), and their expression under environmental conditions is still under investigation. In this study, we investigated the transcriptional regulation of cas operons by CcpA and CodY, two global regulators that contribute to carbohydrate and (p)ppGpp metabolism. The possible promoter regions for cas operons and the binding sites for CcpA and CodY in the promoter regions of both CRISPR-Cas loci were predicted using computational algorithms. We found that CcpA could directly bind to the upstream region of both cas operons, and detected an allosteric interaction of CodY within the same region. The binding sequences of the two regulators were identified through footprinting analysis. Our results showed that the promoter activity of CRISPR1-Cas was enhanced under fructose-rich conditions, while deletion of the ccpA gene led to reduced activity of the CRISPR2-Cas promoter under the same conditions. Additionally, deletion of the CRISPR systems resulted in a significant decrease in fructose uptake ability compared to the parental strain. Interestingly, the accumulation of guanosine tetraphosphate (ppGpp) was reduced in the presence of mupirocin, which induces a stringent response, in the CRISPR1-Cas-deleted (& UDelta;CR1cas) and both CRISPR-Cas-deleted (& UDelta;CRDcas) mutant strains. Furthermore, the promoter activity of both CRISPRs was enhanced in response to oxidative or membrane stress, while the CRISPR1 promoter activity was reduced under low-pH conditions. Collectively, our findings demonstrate that the transcription of the CRISPR-Cas system is directly regulated by the binding of CcpA and CodY. These regulatory actions play a crucial role in modulating glycolytic processes and exerting effective CRISPR-mediated immunity in response to nutrient availability and environmental cues.IMPORTANCE An effective immune system has evolved not only in eukaryotic organisms but also in microorganisms, enabling them to rapidly detect and neutralize foreign invaders in the environment. Specifically, the CRISPR-Cas system in bacterial cells is established through a complex and sophisticated regulatory mechanism involving specific factors. In this study, we demonstrate that the expression of two CRISPR systems in S. mutans can be controlled by two global regulators, CcpA and CodY, which play critical roles in carbohydrate metabolism and amino acid biosynthesis. Importantly, our results show that the expression of the CRISPR-Cas system in S. mutans influences (p)ppGpp production during the stringent response, which is a gene expression regulatory response that aids in environmental stress adaptation. This transcriptional regulation by these regulators enables a CRISPR-mediated immune response in a host environment with limited availability of carbon sources or amino acids, while ensuring efficient carbon flux and energy expenditure to support multiple metabolic processes. An effective immune system has evolved not only in eukaryotic organisms but also in microorganisms, enabling them to rapidly detect and neutralize foreign invaders in the environment. Specifically, the CRISPR-Cas system in bacterial cells is established through a complex and sophisticated regulatory mechanism involving specific factors.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Characterization of a Type II-A CRISPR-Cas System in Streptococcus mutans
    Mosterd, Cas
    Moineau, Sylvain
    MSPHERE, 2020, 5 (03):
  • [2] CcpA and CodY Coordinate Acetate Metabolism in Streptococcus mutans
    Kim, Jeong Nam
    Burne, Robert A.
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2017, 83 (07)
  • [3] The Streptococcus mutans Aminotransferase Encoded by ilvE Is Regulated by CodY and CcpA
    Santiago, Brendaliz
    Marek, Maksym
    Faustoferri, Roberta C.
    Quivey, Robert G., Jr.
    JOURNAL OF BACTERIOLOGY, 2013, 195 (16) : 3552 - 3562
  • [4] Role of the Streptococcus mutans CRISPR-Cas Systems in Immunity and Cell Physiology
    Serbanescu, M. A.
    Cordova, M.
    Krastel, K.
    Flick, R.
    Beloglazova, N.
    Latos, A.
    Yakunin, A. F.
    Senadheera, D. B.
    Cvitkovitch, D. G.
    JOURNAL OF BACTERIOLOGY, 2015, 197 (04) : 749 - 761
  • [5] Primed CRISPR-Cas Adaptation and Impaired Phage Adsorption in Streptococcus mutans
    Mosterd, Cas
    Moineau, Sylvain
    MSPHERE, 2021, 6 (03) : 1 - 14
  • [6] CRISPR-Cas in Streptococcus pyogenes
    Le Rhun, Anais
    Escalera-Maurer, Andres
    Bratovic, Majda
    Charpentier, Emmanuelle
    RNA BIOLOGY, 2019, 16 (04) : 380 - 389
  • [7] Analysis of CRISPR-Cas System in Streptococcus thermophilus and Its Application
    Hao, Mengyuan
    Cui, Yanhua
    Qu, Xiaojun
    FRONTIERS IN MICROBIOLOGY, 2018, 9
  • [8] The CRISPR-Cas system in Enterobacteriaceae
    Medina-Aparicio, Liliana
    Davila, Sonia
    Rebollar-Flores, Javier E.
    Calva, Edmundo
    Hernandez-Lucas, Ismael
    PATHOGENS AND DISEASE, 2018, 76 (01):
  • [9] The CRISPR-Cas system in molecular diagnostics
    Song, Rao
    Chen, Zhongyi
    Xiao, Hongtao
    Wang, Haojun
    CLINICA CHIMICA ACTA, 2024, 561
  • [10] Therapeutic Applications of the CRISPR-Cas System
    Kang, Kyungmin
    Song, Youngjae
    Kim, Inho
    Kim, Tae-Jung
    BIOENGINEERING-BASEL, 2022, 9 (09):